CD14 and type 2 diabetes mellitus: Consistently, a study exploring specific EV-markers in total EVs collected from a large cohort of patients with T2DM and manifest CVDs found that cystatin C levels in EVs were associated with prevalent metabolic syndrome while EV-CD14 levels were associated with a relative risk reduction for the development of T2DM 94.